Skip to content

ClearPoint Maestro CPM-SFW-1

by Clearpoint Neuro, Inc.

ClearPoint Maestro CPM-SFW-1 is an image segmentation application software (FDA Class II; FDA product code QIH, Automated Radiological Image Processing Software) made by Clearpoint Neuro, Inc., listed in FDA GUDID since 4 Oct 2022 (UDI-DI 00850359007966), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00850359007966 UDI-DI Date4 Oct 2022ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
ClearPoint Maestro Brain Model Software Version 1.0
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
ClearPoint Maestro
Generic name
Image segmentation application software
Model / Ref / Catalog
CPM-SFW-1
Primary DI / UDI-DI
00850359007966
FDA product code
QIH
GMDN term
Image segmentation application software
Device class
Class II
Regulation number
892.2050
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code QIH (Automated Radiological Image Processing Software).

Other devices from Clearpoint Neuro, Inc.

See all devices from Clearpoint Neuro, Inc. →

Properties

  • Prescription use
Other properties (14, all answered No)